Matches 1 - 50 out of 191 1 2 3 4 >


Match Document Document Title
US20120022023 Hydraulic Cements, Methods and Products  
Non-aqueous hydraulic cement compositions comprise a non-aqueous mixture of a powder composition and a non-aqueous water-miscible liquid. In one embodiment, powder composition is a Brushite or...
US20120322767 FORMULATIONS OF BISPHOSPHONATES AND VITAMIN D SUIUTABLE FOR INTERMITTENT INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION  
Compositions for pharmaceutical use are described, comprising bisphosphonates and vitamin D in high concentration, destined to the intramuscular and subcutaneous intermittent administration for...
US20130059820 INOSITOL PYROPHOSPHATES, AND METHODS OF USE THEREOF  
The present invention comprises compounds, compositions thereof, and methods capable of delivering modified inositol hexaphosphate (IHP) comprising an internal pyrophosphate ring to the cytoplasm...
US20060287241 Combination comprising N-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazol-2-y1]pyridine-3-sulphonamide and an lhrh analogue and/or bisphosphonate  
A combination, comprising N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-y l]phenyl)pyridine-3-sulphonamide, or a pharmaceutically acceptable salt thereof, and an LHRH analogue and/or...
US20150018316 Compounds, Methods, and Treatments for Abnormal Signaling Pathways for Prenatal and Postnatal Development  
The present invention relates to prevention of congenital deformations. The invention further relates to cancer inhibition and prevention. The invention further relates to methods and compositions...
US20110218176 Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development  
The present invention relates to prevention of congenital deformations. The invention further relates to cancer inhibition and prevention. The invention further relates to methods and compositions...
US20110104301 METHODS OF REDUCING PAIN AND INFLAMMATION  
Provided herein are methods of treating or preventing pain and/or inflammation in a subject comprising administering to the subject a transient receptor potential (TRP) ion channel inhibitor.
US20120040896 COMPOSITIONS, METHODS AND USES FOR MODULATION OF BRCA 1  
Embodiments of the present invention generally relate to methods, compositions and uses for diagnosis and treatment of cancer. Certain embodiments report methods and compositions for diagnosing...
US20130316991 Biologically active supplements and process of its production  
The invention relates to dietary and prophylactic biologically active food supplements (BAS), in particular, from raw plant material and methods for their production; it can be used as a food...
US20050202083 Storage stable tablets of fosinopril sodium  
The technical field of the present invention relates to the selection of lubricants to provide a storage stable tablet of fosinopril, alone or in combination with a diuretic, as well as processes...
US20130337022 PHARMACEUTICAL DOSAGE FORM  
A pH responsive and mucoadhesive pharmaceutical dosage form for the release of a pharmaceutically active agent is described. The dosage form includes a mucoadhesive layer for site-specific...
US20140274966 Drink Product Containing Genistein and Use Thereof  
A drink product having as an active ingredient genistein and an inositol hexaphosphate and/or an unphosphorylated inositol and optionally additional inositol (unphosphorylated as well as...
US20140274965 Drink Product and Use Thereof  
A drink product having as an active ingredient an inositol hexaphosphate and optionally additional inositol moieties. Hexaphosphates for use in the invention include myoinositol hexaphosphate...
US20110070224 METHODS COMPOSITIONS AND DEVICES UTILIZING STINGING CELLS/CAPSULES FOR DELIVERING A THERAPEUTIC OR A COSMETIC AGENT INTO A TISSUE  
A delivery device including at least one stinging capsule and methods of use are described.
US20110269675 STRONTIUM-CONTAINING COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIC BONE CONDITIONS  
A method for the treatment and/or prophylaxis of an osteonecrotic bone disease in a mammal in need thereof, such as, e.g., idiopathic or secondary osteonecrosis, avascular bone necrosis,...
US20130090371 METHODS AND COMPOSITIONS FOR INHIBITION OF BETA2-ADRENERGIC RECEPTOR DEGRADATION  
The present invention generally relates to compositions and kits comprising a β2-AR agonist and a modulator of a β2-AR regulator gene, where the modulator of the β2-AR regulator gene inhibits the...
US20130289621 Drug-Impregnated Encasement  
A drug-impregnated sleeve for encasing a medical implant is provided. In one embodiment, the sleeve may include a body made of a biologically-compatible material that defines an internal cavity...
US20070077267 Bioactive composite implants  
A composite spinal implant device including collagen and/or synthetic fibers impregnated with a bioactive formulation is disclosed. Also disclosed are methods of making the composite spinal...
US20130089604 Solid Oral Dosage Form Containing An Enhancer  
The invention relates to a solid oral dosage form comprising a pharmaceutically active ingredient in combination with an enhancer which enhances the bioavailability and/or the absorption of the...
US20060166937 Bisphosphonates for the treatment of atherosclerosis and device comprising them  
A method for the treatment of atherosclerosis, in particular atherosclerotic/valve calcification and plaque rupture/stroke, in a patient in need of such treatment, e.g. a patient with aterial or...
US20050148521 Anti-cancer combination and use thereof  
The present invention relates to the surprising discovery that the combination of several agents, each well known for its established role in treating cancer, inflammation, hemostasis, bone...
US20140296134 METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION  
Embodiments include methods for generating a metabolite profile of a stool sample and methods of assessing the status of a subject using the metabolic profile derived from a stool sample.
US20070142336 Treatment of cancer  
The invention relates to the treatment of cancers, in particular, cancers that are resistant to platinum based chemotherapeutic agents. A pharmaceutical composition for the treatment of cancer...
US20050176685 Method for inhibiting bone resorption with an alendronate and vitamin d formulation  
Composition and method for preventing or treating abnormal bone resorption in mammals, the composition characterized as containing, a supplementary effective amount of a non-activated metabolite...
US20060046982 Orthomolecular medical use of L-citrulline for capillary endothelial protection and adjacent cell protection in neurodegenerative disease  
This invention embodies use of exogenous L-citrulline not only for support of capillary endothelial function, by L-citrulline bioconversion to plasma L-arginine to provide more cell substrate for...
US20120165296 BISPHOSPHONATE-PRODRUGS  
The present invention relates to a prodrug, comprising a pharmaceutically and/or diagnostically active compound, and one or more bisphosphonate groups, to a process for producing such a prodrug,...
US20070066574 MYO-INOSITOL HEXAPHOSPHATE FOR TOPICAL USE  
The invention relates to a composition that includes myo-inositol hexaphosphate applied by topical administration for utilisation in the treatment or prevention of a disease associated with the...
US20130302448 PHYTIN AQUEOUS SOLUTION AND USE OF SAID SOLUTION FOR THE PREPARATION OF A LIQUID NUTRITIONAL SUPPLEMENT OR A COSMETIC COMPOSITION  
A phytin aqueous solution including at least one alpha-hydroxylated carboxylic acid and phytin in a solubilized form, preferably in a concentration ranging from 70 g/L to 270 g/L, and in that it...
US20050187195 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans  
The compounds of formula (I) are hydrophilic aryl phosphate, thiophosphate, and aminophosphate intestinal apical membrane Na-mediated phosphate co-transportation inhibitors. The compounds can be...
US20080021001 Methods For Treating Arthritic Conditions In Dogs  
The present invention relates to a method for eliciting a disease modifying effect on an arthritic condition in a hip or stifle of a canine which comprises administering to the canine a...
US20070116778 Antibacterial, antiviral, and antifungal nutritional supplement: a combination of natural or neutraceutical compounds shown to have antibacterial, antiviral, and antifungal properties, to help boost the immune system in humans, and to protect against certain biowarfare diseases  
Certain compounds have been shown to provide antibacterial, antiviral, and antifungal properties. These compounds can provide some of the beneficial aspects of medicinal antibiotics without...
US20060078531 Method of prevention and treatment of atherosclerosis, peripheral vascular disease, coronary artery disease, and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease  
This invention relates to a method for prevention and treatment of Atherosclerosis, Peripheral Vascular Disease, Coronary Artery Disease, and age-related disorders including Osteoporosis,...
US20130184206 Selective androgen receptor modulators (SARMs) and uses thereof  
Provided herein are compounds that bind to androgen receptors and/or modulate activity of androgen receptors. Also provided are methods for making and using such compounds. Also provided are...
US20080075664 Control Of Diabetes And Obesity  
Provided are methods of increasing resistance to and methods of treating disorders associated with weight gain. Also provided are methods of screening for an agent that prevents or treats a...
US20070032457 Combination therapy for cancer treatment  
The present invention provides methods of treating cancer, the methods generally involving combination therapy. The methods are useful as primary cancer therapy, or as adjuvant therapy. The...
US20050009868 Retinoid receptor pan-antagonists for stimulating chondrogenesis  
The invention relates to methods and compositions for inducing or enhancing chondrogenesis in vivo and/or ex vivo. More specifically, the invention is directed to the use of RAR pan-antagonist...
US20150250759 COMPOSITION FOR INHIBITION OF CATHEPSIN K  
The present invention relates to the a method of inhibiting bone resorption in a mammal in need thereof with an oral pharmaceutical composition comprising a cathepsin K inhibitor, or a...
US20140186471 COMPOSITION FOR INHIBITION OF CATHEPSIN K  
The present invention relates to the a method of inhibiting bone resorption in a mammal in need thereof with an oral pharmaceutical composition comprising a cathepsin K inhibitor, or a...
US20130023879 METHOD FOR AUGMENTING, REDUCING, AND REPAIRING BONE WITH THERMOPLASTIC MATERIALS (AS AMENDED)  
A method for augmenting a tissue including introducing into the tissue a first thermoplastic material at a first condition; treating the first thermoplastic material to achieve a second condition...
US20100047306 PHARMACEUTICAL COMPOSITIONS COMPRISING BISPHOSPONATES  
The present invention relates to depot formulations comprising a poorly water soluble salt of a bisphosphonate forming together with one or more biocompatible polymers. The depot formulation may...
US20110319364 FOAMING ALCOHOL COMPOSITIONS WITH SELECTED DIMETHICONE SURFACTANTS  
Foaming alcohol compositions with selected dimethicone surfactants are disclosed. The dimethicone surfactants are PEG-8 to PEG-12 linear dimethicone surfactants and in particular PEG-10 linear...
US20060210639 Nanoparticulate bisphosphonate compositions  
Nanoparticulate bisphosphonate compositions, having an effective average particle size of less than 2000 nm, are described. The compositions are useful in treating bone resorption in a mammal.
US20070066571 Novel bisphosphonates having anti-inflammatory and/or pain-killing properties  
This invention describes new and novel bisphosphonate conjugates having anti-inflammatory and/or pain-killing properties.
US20050063902 Stabiliser for radiopharmaceuticals  
The present invention provides an improved stabiliser for radiopharmaceuticals which inhibits impurities from being produced by two kinds of decomposition mechanisms and exhibits such an effect...
US20120135930 METHODS OF CORRECTING IMBALANCE BETWEEN BONE RESORPTION AND BONE FORMATION AND KITS AND COMPOSITIONS THEREFOR  
Compounds, methods, uses, compositions, kits and packages for the treatment of imbalance between bone resorption and bone formation, based on uses of 4-phenyl-2-propionamidotetralin (4-P-PDOT) and...
US20050113343 Solid-state form of alendronate sodium and preparation thereof  
A new solid-state form of alendronate sodium and process for its preparation are provided. The disclosure is also directed to pharmaceutical compositions containing the solid-state form, and to...
US20080182822 Liquid Pharmaceutical Compositions Comprising a Bisphosphonate Compound  
The present invention relates to liquid pharmaceutical compositions comprising a bisphosphonate compound.
US20050037089 Method for promoting bone growth  
A method for treating a patient to promote bone growth, comprising: administering to the patient a therapeutic amount of a bone remodeling agent effective to stimulate bone growth, and a dietary...
US20070225258 COMPOSITIONS COMPRISING BISPHOSPHONATE AND AN ANTIFOLATE  
Compositions and methods for the treatment of arthritis, particularly rheumatoid arthritis and osteoarthritis. These compositions include at least one antifolate and at least one bisphosphonate,...
US20060241086 Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin  
The present invention relates to various salts of inositol tripyrophosphate including the calcium, lithium, beryllium, magnesium, potassium, strontium, barium, rubidium and cesium salts of...

Matches 1 - 50 out of 191 1 2 3 4 >